​Principal Investigator: Dr. Anisur Rahman

Disease: Prenatal Nutrition

Research Description: Up to 40% of Bangladeshi newborns are born preterm or small for gestational age, called Small Vulnerable Newborns (SVNs). SVNs have low birth weight, increasing their mortality risk and health adversities throughout their lives. Despite efforts to improve prenatal nutrition and care, there remains a need for inexpensive and accessible alternative interventions. This double-blind, randomized, placebo-controlled trial is testing sulfadoxine-pyrimethamine, an antimicrobial widely used for malaria prevention, to improve maternal gut health and gestational weight gain during pregnancy while limiting infection and inflammation. Positive results could potentially impact at-risk pregnancies worldwide.

Funding Partners: Coefficient Giving

Initial CWR Funding Role: Supplemental